Particle Therapy Market – Overview
This report on the particle therapy market analyses the current and future scenario of the global market. Large number of cancer patients opting for particle therapy and incidences of brain tumor occurrence among the geriatric population are boosting the usage of proton and carbon therapy. Less pain and high definition healing technology are major drivers of the global particle therapy market.
The particle therapy market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on services, therapy, cancer application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises major player’s product portfolio-based on technology & cancer application to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global particle therapy market.
Request Brochure for Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56133
Particle Therapy Market – Snapshot
The global particle therapy market is expanding owing to the increasing prevalence and incidence of cancer disease across the globe. The global particle therapy market was valued at US$ 364.8 Mn in 2017 and is projected to reach a value of US$ 727.0 Mn by 2026, expanding at a compound annual growth rate (CAGR) of over 8.0% from 2018 to 2026. The global market is expanding at a relatively higher growth rate owing to increasing digitization of pain management practices, high incidences of cancer treatment, occurrence of brain tumors among the geriatric population, lung cancer among adult men & women, and rise in demand for surgery-free treatment procedure.
Particle therapy is a form of external beam radiotherapy that utilizes beams of energetic protons, neutrons, or positive ions for cancer treatment. The most common type of particle therapy used for cancer treatment is proton therapy. However, carbon therapy employs particles in a more massive way than protons and other neutrons. The technique is gaining scientific attention due to improved clinical studies for the treatment of several cancers such as prostate, head and neck, lung, and liver, bone and soft tissue sarcomas, locally recurrent rectal cancer, and pancreatic cancer, including locally advanced disease. Carbon-ions are heavier than protons, which provides higher relative biological effectiveness (RBE) and increases the accumulation of carbon ions near the tumor for deeper treatment procedure.
Request for Analysis of COVID19 Impact on Particle Therapy Market:
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=56133
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Key Players of Particle Therapy market Report:
Companies such as Varian Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, and Sumitomo Heavy Industries, Ltd. accounted for a major share of the global particle therapy market in 2017. In April 2017, IBA Worldwide and Toshiba Medical Systems Corporation announced the signing of a global collaboration to expand access to proton therapy worldwide. Toshiba has become the distributor in Japan for Proteus ONE, and IBA has become the agent for Toshiba’s Carbon Therapy Solutions outside Japan. Other global players operating in the market include Advanced Oncotherapy PLC., Mevion Medical Systems, Inc., Provision Healthcare, LLC, Optivus Proton Therapy, Inc., Protom International, Inc., and Danfysik A/S. These companies are focusing on strategy acquisition and collaboration with parallel companies in order to improve and strengthen their geographic presence in the global market.
Buy Particle Therapy Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=56133<ype=S
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
